nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—ABCB1—colon cancer	0.51	1	CbGaD
Clomifene—CYP2A6—Fluorouracil—colon cancer	0.0901	0.384	CbGbCtD
Clomifene—CYP1A2—Fluorouracil—colon cancer	0.0344	0.146	CbGbCtD
Clomifene—ABCB1—Irinotecan—colon cancer	0.0313	0.133	CbGbCtD
Clomifene—ABCB1—Vincristine—colon cancer	0.0274	0.117	CbGbCtD
Clomifene—CYP3A4—Irinotecan—colon cancer	0.0188	0.0799	CbGbCtD
Clomifene—ABCB1—Methotrexate—colon cancer	0.0166	0.0706	CbGbCtD
Clomifene—CYP3A4—Vincristine—colon cancer	0.0164	0.0698	CbGbCtD
Clomifene—Acute abdomen—Vincristine—colon cancer	0.0161	0.0894	CcSEcCtD
Clomifene—Ventricular septal defect—Fluorouracil—colon cancer	0.0129	0.0721	CcSEcCtD
Clomifene—Ichthyosis—Fluorouracil—colon cancer	0.00936	0.0521	CcSEcCtD
Clomifene—Ichthyosis acquired—Fluorouracil—colon cancer	0.00936	0.0521	CcSEcCtD
Clomifene—Prolonged menses—Vincristine—colon cancer	0.00552	0.0307	CcSEcCtD
Clomifene—Leukaemia—Vincristine—colon cancer	0.00429	0.0239	CcSEcCtD
Clomifene—Thromboembolic event—Irinotecan—colon cancer	0.00418	0.0233	CcSEcCtD
Clomifene—Hypovolaemia—Irinotecan—colon cancer	0.00363	0.0202	CcSEcCtD
Clomifene—Mental retardation—Capecitabine—colon cancer	0.00345	0.0192	CcSEcCtD
Clomifene—Congenital anomaly—Fluorouracil—colon cancer	0.00284	0.0158	CcSEcCtD
Clomifene—Developmental delay—Fluorouracil—colon cancer	0.00284	0.0158	CcSEcCtD
Clomifene—Thromboembolic event—Capecitabine—colon cancer	0.0028	0.0156	CcSEcCtD
Clomifene—EBP—liver—colon cancer	0.00221	0.0704	CbGeAlD
Clomifene—Vasospasm—Capecitabine—colon cancer	0.00221	0.0123	CcSEcCtD
Clomifene—Blindness—Vincristine—colon cancer	0.00209	0.0116	CcSEcCtD
Clomifene—Leukaemia—Methotrexate—colon cancer	0.00208	0.0116	CcSEcCtD
Clomifene—Thromboembolic event—Methotrexate—colon cancer	0.00208	0.0116	CcSEcCtD
Clomifene—Congenital anomaly—Capecitabine—colon cancer	0.00198	0.011	CcSEcCtD
Clomifene—Developmental delay—Capecitabine—colon cancer	0.00198	0.011	CcSEcCtD
Clomifene—ESR1—blood vessel—colon cancer	0.00191	0.0609	CbGeAlD
Clomifene—Embolism—Irinotecan—colon cancer	0.00175	0.00977	CcSEcCtD
Clomifene—Ascites—Capecitabine—colon cancer	0.00166	0.00923	CcSEcCtD
Clomifene—Thrombosis—Irinotecan—colon cancer	0.00159	0.00886	CcSEcCtD
Clomifene—Disorder sight—Capecitabine—colon cancer	0.00158	0.00881	CcSEcCtD
Clomifene—Menorrhagia—Vincristine—colon cancer	0.00156	0.0087	CcSEcCtD
Clomifene—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00131	0.00731	CcSEcCtD
Clomifene—Visual acuity reduced—Capecitabine—colon cancer	0.00127	0.00706	CcSEcCtD
Clomifene—Tenderness—Fluorouracil—colon cancer	0.00124	0.00688	CcSEcCtD
Clomifene—Embolism—Capecitabine—colon cancer	0.00117	0.00654	CcSEcCtD
Clomifene—Blood triglycerides increased—Capecitabine—colon cancer	0.00115	0.0064	CcSEcCtD
Clomifene—Leukocytosis—Fluorouracil—colon cancer	0.00115	0.00639	CcSEcCtD
Clomifene—ESR1—embryo—colon cancer	0.00114	0.0363	CbGeAlD
Clomifene—Pulmonary embolism—Irinotecan—colon cancer	0.00113	0.00627	CcSEcCtD
Clomifene—Thrombosis—Capecitabine—colon cancer	0.00106	0.00593	CcSEcCtD
Clomifene—Neoplasm—Irinotecan—colon cancer	0.00102	0.00567	CcSEcCtD
Clomifene—SIGMAR1—smooth muscle tissue—colon cancer	0.00101	0.0323	CbGeAlD
Clomifene—Photophobia—Fluorouracil—colon cancer	0.00101	0.00564	CcSEcCtD
Clomifene—Thrombophlebitis—Irinotecan—colon cancer	0.000944	0.00526	CcSEcCtD
Clomifene—Deafness—Vincristine—colon cancer	0.000938	0.00522	CcSEcCtD
Clomifene—ESR1—epithelium—colon cancer	0.00093	0.0296	CbGeAlD
Clomifene—CYP2A6—vagina—colon cancer	0.000917	0.0292	CbGeAlD
Clomifene—Thrombophlebitis—Fluorouracil—colon cancer	0.000904	0.00504	CcSEcCtD
Clomifene—ESR1—smooth muscle tissue—colon cancer	0.000896	0.0286	CbGeAlD
Clomifene—Embolism—Methotrexate—colon cancer	0.000874	0.00487	CcSEcCtD
Clomifene—ESR1—renal system—colon cancer	0.000863	0.0275	CbGeAlD
Clomifene—Visual disturbance—Irinotecan—colon cancer	0.000863	0.0048	CcSEcCtD
Clomifene—Cyst—Methotrexate—colon cancer	0.000839	0.00467	CcSEcCtD
Clomifene—Cerebrovascular accident—Irinotecan—colon cancer	0.000834	0.00464	CcSEcCtD
Clomifene—Liver disorder—Methotrexate—colon cancer	0.000823	0.00458	CcSEcCtD
Clomifene—Cataract—Capecitabine—colon cancer	0.000792	0.00441	CcSEcCtD
Clomifene—KCNH2—renal system—colon cancer	0.000777	0.0248	CbGeAlD
Clomifene—CYP2A6—liver—colon cancer	0.000774	0.0247	CbGeAlD
Clomifene—ABCB1—blood vessel—colon cancer	0.000755	0.0241	CbGeAlD
Clomifene—Pulmonary embolism—Capecitabine—colon cancer	0.000754	0.0042	CcSEcCtD
Clomifene—Irritability—Fluorouracil—colon cancer	0.000747	0.00416	CcSEcCtD
Clomifene—SIGMAR1—bone marrow—colon cancer	0.000738	0.0235	CbGeAlD
Clomifene—ESR1—lymphoid tissue—colon cancer	0.000716	0.0228	CbGeAlD
Clomifene—CYP11A1—lymph node—colon cancer	0.000716	0.0228	CbGeAlD
Clomifene—Abdominal distension—Irinotecan—colon cancer	0.000711	0.00396	CcSEcCtD
Clomifene—ESR1—digestive system—colon cancer	0.000708	0.0225	CbGeAlD
Clomifene—CYP1A1—epithelium—colon cancer	0.000707	0.0225	CbGeAlD
Clomifene—SIGMAR1—vagina—colon cancer	0.000707	0.0225	CbGeAlD
Clomifene—Pancreatitis—Irinotecan—colon cancer	0.000693	0.00386	CcSEcCtD
Clomifene—Neoplasm—Capecitabine—colon cancer	0.000681	0.00379	CcSEcCtD
Clomifene—CYP1A2—renal system—colon cancer	0.000665	0.0212	CbGeAlD
Clomifene—CYP1A1—renal system—colon cancer	0.000656	0.0209	CbGeAlD
Clomifene—Mental disability—Capecitabine—colon cancer	0.000654	0.00364	CcSEcCtD
Clomifene—Phlebitis—Capecitabine—colon cancer	0.000635	0.00354	CcSEcCtD
Clomifene—Thrombophlebitis—Capecitabine—colon cancer	0.000632	0.00352	CcSEcCtD
Clomifene—ESR1—vagina—colon cancer	0.000625	0.0199	CbGeAlD
Clomifene—Renal failure—Irinotecan—colon cancer	0.000619	0.00345	CcSEcCtD
Clomifene—Jaundice—Irinotecan—colon cancer	0.000614	0.00342	CcSEcCtD
Clomifene—Deafness—Capecitabine—colon cancer	0.000612	0.00341	CcSEcCtD
Clomifene—CYP19A1—liver—colon cancer	0.000607	0.0193	CbGeAlD
Clomifene—Eye pain—Capecitabine—colon cancer	0.000606	0.00337	CcSEcCtD
Clomifene—CYP2E1—renal system—colon cancer	0.000598	0.0191	CbGeAlD
Clomifene—SIGMAR1—liver—colon cancer	0.000596	0.019	CbGeAlD
Clomifene—KCNH2—bone marrow—colon cancer	0.000587	0.0187	CbGeAlD
Clomifene—Hot flush—Capecitabine—colon cancer	0.000585	0.00326	CcSEcCtD
Clomifene—Increased appetite—Capecitabine—colon cancer	0.000582	0.00324	CcSEcCtD
Clomifene—Menopausal symptoms—Capecitabine—colon cancer	0.00058	0.00323	CcSEcCtD
Clomifene—KCNH2—vagina—colon cancer	0.000563	0.0179	CbGeAlD
Clomifene—Pulmonary embolism—Methotrexate—colon cancer	0.000561	0.00312	CcSEcCtD
Clomifene—Cerebrovascular accident—Capecitabine—colon cancer	0.000558	0.00311	CcSEcCtD
Clomifene—Diplopia—Capecitabine—colon cancer	0.000547	0.00305	CcSEcCtD
Clomifene—CYP1A2—digestive system—colon cancer	0.000545	0.0174	CbGeAlD
Clomifene—Visual impairment—Irinotecan—colon cancer	0.000545	0.00303	CcSEcCtD
Clomifene—Migraine—Capecitabine—colon cancer	0.000539	0.003	CcSEcCtD
Clomifene—CYP1A1—digestive system—colon cancer	0.000538	0.0171	CbGeAlD
Clomifene—ESR1—liver—colon cancer	0.000527	0.0168	CbGeAlD
Clomifene—Flushing—Irinotecan—colon cancer	0.000525	0.00292	CcSEcCtD
Clomifene—Irritability—Capecitabine—colon cancer	0.000522	0.00291	CcSEcCtD
Clomifene—Mood swings—Capecitabine—colon cancer	0.000518	0.00289	CcSEcCtD
Clomifene—Alopecia—Vincristine—colon cancer	0.000513	0.00286	CcSEcCtD
Clomifene—Neoplasm—Methotrexate—colon cancer	0.000507	0.00282	CcSEcCtD
Clomifene—Arrhythmia—Irinotecan—colon cancer	0.000505	0.00281	CcSEcCtD
Clomifene—Alopecia—Irinotecan—colon cancer	0.0005	0.00278	CcSEcCtD
Clomifene—CYP2E1—lymphoid tissue—colon cancer	0.000497	0.0158	CbGeAlD
Clomifene—CYP2E1—digestive system—colon cancer	0.000491	0.0156	CbGeAlD
Clomifene—Back pain—Vincristine—colon cancer	0.000489	0.00272	CcSEcCtD
Clomifene—Flatulence—Irinotecan—colon cancer	0.000485	0.0027	CcSEcCtD
Clomifene—Arrhythmia—Fluorouracil—colon cancer	0.000484	0.00269	CcSEcCtD
Clomifene—CYP3A4—renal system—colon cancer	0.000481	0.0153	CbGeAlD
Clomifene—Alopecia—Fluorouracil—colon cancer	0.000479	0.00266	CcSEcCtD
Clomifene—Back pain—Irinotecan—colon cancer	0.000476	0.00265	CcSEcCtD
Clomifene—Abdominal distension—Capecitabine—colon cancer	0.000476	0.00265	CcSEcCtD
Clomifene—CYP1A1—vagina—colon cancer	0.000475	0.0151	CbGeAlD
Clomifene—Erythema—Fluorouracil—colon cancer	0.000472	0.00263	CcSEcCtD
Clomifene—Thrombophlebitis—Methotrexate—colon cancer	0.00047	0.00262	CcSEcCtD
Clomifene—CYP19A1—lymph node—colon cancer	0.000465	0.0148	CbGeAlD
Clomifene—SIGMAR1—lymph node—colon cancer	0.000457	0.0146	CbGeAlD
Clomifene—Vertigo—Vincristine—colon cancer	0.000454	0.00253	CcSEcCtD
Clomifene—Abdominal discomfort—Capecitabine—colon cancer	0.000453	0.00252	CcSEcCtD
Clomifene—ABCB1—embryo—colon cancer	0.00045	0.0143	CbGeAlD
Clomifene—Vision blurred—Fluorouracil—colon cancer	0.000444	0.00247	CcSEcCtD
Clomifene—Vertigo—Irinotecan—colon cancer	0.000442	0.00246	CcSEcCtD
Clomifene—Syncope—Irinotecan—colon cancer	0.000441	0.00246	CcSEcCtD
Clomifene—Convulsion—Vincristine—colon cancer	0.000438	0.00244	CcSEcCtD
Clomifene—Hypertension—Vincristine—colon cancer	0.000436	0.00243	CcSEcCtD
Clomifene—Loss of consciousness—Irinotecan—colon cancer	0.000433	0.00241	CcSEcCtD
Clomifene—Myalgia—Vincristine—colon cancer	0.00043	0.0024	CcSEcCtD
Clomifene—Weight increased—Capecitabine—colon cancer	0.00043	0.0024	CcSEcCtD
Clomifene—Visual disturbance—Methotrexate—colon cancer	0.00043	0.00239	CcSEcCtD
Clomifene—Hypertension—Irinotecan—colon cancer	0.000425	0.00237	CcSEcCtD
Clomifene—Cerebrovascular accident—Methotrexate—colon cancer	0.000416	0.00231	CcSEcCtD
Clomifene—Renal failure—Capecitabine—colon cancer	0.000414	0.00231	CcSEcCtD
Clomifene—Oedema—Vincristine—colon cancer	0.000413	0.0023	CcSEcCtD
Clomifene—Jaundice—Capecitabine—colon cancer	0.000411	0.00229	CcSEcCtD
Clomifene—Convulsion—Fluorouracil—colon cancer	0.000409	0.00227	CcSEcCtD
Clomifene—CYP1A2—liver—colon cancer	0.000406	0.013	CbGeAlD
Clomifene—ESR1—lymph node—colon cancer	0.000404	0.0129	CbGeAlD
Clomifene—Oedema—Irinotecan—colon cancer	0.000402	0.00224	CcSEcCtD
Clomifene—Chest pain—Fluorouracil—colon cancer	0.000401	0.00223	CcSEcCtD
Clomifene—Myalgia—Fluorouracil—colon cancer	0.000401	0.00223	CcSEcCtD
Clomifene—CYP1A1—liver—colon cancer	0.000401	0.0128	CbGeAlD
Clomifene—Shock—Irinotecan—colon cancer	0.000395	0.0022	CcSEcCtD
Clomifene—CYP3A4—digestive system—colon cancer	0.000395	0.0126	CbGeAlD
Clomifene—Irritability—Methotrexate—colon cancer	0.000389	0.00216	CcSEcCtD
Clomifene—Mood swings—Methotrexate—colon cancer	0.000386	0.00215	CcSEcCtD
Clomifene—Oedema—Fluorouracil—colon cancer	0.000385	0.00214	CcSEcCtD
Clomifene—Hepatitis—Capecitabine—colon cancer	0.000378	0.00211	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vincristine—colon cancer	0.000376	0.00209	CcSEcCtD
Clomifene—Tachycardia—Fluorouracil—colon cancer	0.000376	0.00209	CcSEcCtD
Clomifene—Insomnia—Vincristine—colon cancer	0.000373	0.00208	CcSEcCtD
Clomifene—Paraesthesia—Vincristine—colon cancer	0.00037	0.00206	CcSEcCtD
Clomifene—ABCB1—epithelium—colon cancer	0.000367	0.0117	CbGeAlD
Clomifene—CYP2E1—liver—colon cancer	0.000366	0.0116	CbGeAlD
Clomifene—Visual impairment—Capecitabine—colon cancer	0.000365	0.00203	CcSEcCtD
Clomifene—KCNH2—lymph node—colon cancer	0.000364	0.0116	CbGeAlD
Clomifene—Insomnia—Irinotecan—colon cancer	0.000363	0.00202	CcSEcCtD
Clomifene—Paraesthesia—Irinotecan—colon cancer	0.000361	0.00201	CcSEcCtD
Clomifene—Dyspnoea—Irinotecan—colon cancer	0.000358	0.00199	CcSEcCtD
Clomifene—Erythema multiforme—Capecitabine—colon cancer	0.000358	0.00199	CcSEcCtD
Clomifene—Fatigue—Vincristine—colon cancer	0.000356	0.00198	CcSEcCtD
Clomifene—Tinnitus—Capecitabine—colon cancer	0.000353	0.00196	CcSEcCtD
Clomifene—Pain—Vincristine—colon cancer	0.000353	0.00196	CcSEcCtD
Clomifene—Constipation—Vincristine—colon cancer	0.000353	0.00196	CcSEcCtD
Clomifene—Flushing—Capecitabine—colon cancer	0.000351	0.00196	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000351	0.00195	CcSEcCtD
Clomifene—Insomnia—Fluorouracil—colon cancer	0.000348	0.00194	CcSEcCtD
Clomifene—Fatigue—Irinotecan—colon cancer	0.000346	0.00193	CcSEcCtD
Clomifene—Paraesthesia—Fluorouracil—colon cancer	0.000346	0.00192	CcSEcCtD
Clomifene—Pancreatitis—Methotrexate—colon cancer	0.000345	0.00192	CcSEcCtD
Clomifene—Constipation—Irinotecan—colon cancer	0.000344	0.00191	CcSEcCtD
Clomifene—Pain—Irinotecan—colon cancer	0.000344	0.00191	CcSEcCtD
Clomifene—Dyspnoea—Fluorouracil—colon cancer	0.000343	0.00191	CcSEcCtD
Clomifene—ABCB1—renal system—colon cancer	0.000341	0.0109	CbGeAlD
Clomifene—Arrhythmia—Capecitabine—colon cancer	0.000338	0.00188	CcSEcCtD
Clomifene—Abdominal discomfort—Methotrexate—colon cancer	0.000337	0.00188	CcSEcCtD
Clomifene—Alopecia—Capecitabine—colon cancer	0.000334	0.00186	CcSEcCtD
Clomifene—Erythema—Capecitabine—colon cancer	0.000329	0.00183	CcSEcCtD
Clomifene—Pain—Fluorouracil—colon cancer	0.000329	0.00183	CcSEcCtD
Clomifene—Body temperature increased—Vincristine—colon cancer	0.000326	0.00182	CcSEcCtD
Clomifene—Flatulence—Capecitabine—colon cancer	0.000325	0.00181	CcSEcCtD
Clomifene—Back pain—Capecitabine—colon cancer	0.000319	0.00177	CcSEcCtD
Clomifene—Body temperature increased—Irinotecan—colon cancer	0.000318	0.00177	CcSEcCtD
Clomifene—Vision blurred—Capecitabine—colon cancer	0.000311	0.00173	CcSEcCtD
Clomifene—Renal failure—Methotrexate—colon cancer	0.000309	0.00172	CcSEcCtD
Clomifene—CYP1A1—lymph node—colon cancer	0.000307	0.00979	CbGeAlD
Clomifene—Urticaria—Fluorouracil—colon cancer	0.000306	0.0017	CcSEcCtD
Clomifene—Body temperature increased—Fluorouracil—colon cancer	0.000304	0.00169	CcSEcCtD
Clomifene—Hypersensitivity—Vincristine—colon cancer	0.000304	0.00169	CcSEcCtD
Clomifene—Vertigo—Capecitabine—colon cancer	0.000296	0.00165	CcSEcCtD
Clomifene—Hypersensitivity—Irinotecan—colon cancer	0.000296	0.00165	CcSEcCtD
Clomifene—Asthenia—Vincristine—colon cancer	0.000296	0.00165	CcSEcCtD
Clomifene—Syncope—Capecitabine—colon cancer	0.000295	0.00165	CcSEcCtD
Clomifene—CYP3A4—liver—colon cancer	0.000294	0.00937	CbGeAlD
Clomifene—Palpitations—Capecitabine—colon cancer	0.000291	0.00162	CcSEcCtD
Clomifene—Loss of consciousness—Capecitabine—colon cancer	0.00029	0.00161	CcSEcCtD
Clomifene—Asthenia—Irinotecan—colon cancer	0.000288	0.0016	CcSEcCtD
Clomifene—Hypertension—Capecitabine—colon cancer	0.000284	0.00158	CcSEcCtD
Clomifene—Hypersensitivity—Fluorouracil—colon cancer	0.000284	0.00158	CcSEcCtD
Clomifene—ABCB1—lymphoid tissue—colon cancer	0.000283	0.00902	CbGeAlD
Clomifene—Diarrhoea—Vincristine—colon cancer	0.000282	0.00157	CcSEcCtD
Clomifene—Hepatitis—Methotrexate—colon cancer	0.000282	0.00157	CcSEcCtD
Clomifene—Arthralgia—Capecitabine—colon cancer	0.000281	0.00156	CcSEcCtD
Clomifene—Chest pain—Capecitabine—colon cancer	0.000281	0.00156	CcSEcCtD
Clomifene—Myalgia—Capecitabine—colon cancer	0.000281	0.00156	CcSEcCtD
Clomifene—Anxiety—Capecitabine—colon cancer	0.00028	0.00156	CcSEcCtD
Clomifene—ABCB1—digestive system—colon cancer	0.000279	0.00891	CbGeAlD
Clomifene—Diarrhoea—Irinotecan—colon cancer	0.000275	0.00153	CcSEcCtD
Clomifene—Dizziness—Vincristine—colon cancer	0.000273	0.00152	CcSEcCtD
Clomifene—Pruritus—Fluorouracil—colon cancer	0.000272	0.00152	CcSEcCtD
Clomifene—Visual impairment—Methotrexate—colon cancer	0.000272	0.00151	CcSEcCtD
Clomifene—Oedema—Capecitabine—colon cancer	0.000269	0.0015	CcSEcCtD
Clomifene—Erythema multiforme—Methotrexate—colon cancer	0.000266	0.00148	CcSEcCtD
Clomifene—Dizziness—Irinotecan—colon cancer	0.000266	0.00148	CcSEcCtD
Clomifene—Shock—Capecitabine—colon cancer	0.000265	0.00147	CcSEcCtD
Clomifene—Diarrhoea—Fluorouracil—colon cancer	0.000263	0.00147	CcSEcCtD
Clomifene—Tinnitus—Methotrexate—colon cancer	0.000263	0.00146	CcSEcCtD
Clomifene—Tachycardia—Capecitabine—colon cancer	0.000262	0.00146	CcSEcCtD
Clomifene—Vomiting—Vincristine—colon cancer	0.000262	0.00146	CcSEcCtD
Clomifene—Rash—Vincristine—colon cancer	0.00026	0.00145	CcSEcCtD
Clomifene—Dermatitis—Vincristine—colon cancer	0.00026	0.00145	CcSEcCtD
Clomifene—Headache—Vincristine—colon cancer	0.000258	0.00144	CcSEcCtD
Clomifene—ABCB1—bone marrow—colon cancer	0.000258	0.00821	CbGeAlD
Clomifene—Vomiting—Irinotecan—colon cancer	0.000255	0.00142	CcSEcCtD
Clomifene—Dizziness—Fluorouracil—colon cancer	0.000254	0.00142	CcSEcCtD
Clomifene—Rash—Irinotecan—colon cancer	0.000253	0.00141	CcSEcCtD
Clomifene—Dermatitis—Irinotecan—colon cancer	0.000253	0.00141	CcSEcCtD
Clomifene—Headache—Irinotecan—colon cancer	0.000252	0.0014	CcSEcCtD
Clomifene—Alopecia—Methotrexate—colon cancer	0.000249	0.00139	CcSEcCtD
Clomifene—ABCB1—vagina—colon cancer	0.000247	0.00787	CbGeAlD
Clomifene—Erythema—Methotrexate—colon cancer	0.000245	0.00137	CcSEcCtD
Clomifene—Nausea—Vincristine—colon cancer	0.000245	0.00136	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000245	0.00136	CcSEcCtD
Clomifene—Vomiting—Fluorouracil—colon cancer	0.000245	0.00136	CcSEcCtD
Clomifene—Insomnia—Capecitabine—colon cancer	0.000243	0.00135	CcSEcCtD
Clomifene—Rash—Fluorouracil—colon cancer	0.000243	0.00135	CcSEcCtD
Clomifene—Dermatitis—Fluorouracil—colon cancer	0.000242	0.00135	CcSEcCtD
Clomifene—Paraesthesia—Capecitabine—colon cancer	0.000241	0.00134	CcSEcCtD
Clomifene—Headache—Fluorouracil—colon cancer	0.000241	0.00134	CcSEcCtD
Clomifene—Dyspnoea—Capecitabine—colon cancer	0.00024	0.00133	CcSEcCtD
Clomifene—Nausea—Irinotecan—colon cancer	0.000239	0.00133	CcSEcCtD
Clomifene—Back pain—Methotrexate—colon cancer	0.000237	0.00132	CcSEcCtD
Clomifene—Fatigue—Capecitabine—colon cancer	0.000232	0.00129	CcSEcCtD
Clomifene—Vision blurred—Methotrexate—colon cancer	0.000231	0.00129	CcSEcCtD
Clomifene—Constipation—Capecitabine—colon cancer	0.00023	0.00128	CcSEcCtD
Clomifene—Pain—Capecitabine—colon cancer	0.00023	0.00128	CcSEcCtD
Clomifene—Nausea—Fluorouracil—colon cancer	0.000229	0.00127	CcSEcCtD
Clomifene—Vertigo—Methotrexate—colon cancer	0.00022	0.00123	CcSEcCtD
Clomifene—Urticaria—Capecitabine—colon cancer	0.000214	0.00119	CcSEcCtD
Clomifene—Body temperature increased—Capecitabine—colon cancer	0.000213	0.00118	CcSEcCtD
Clomifene—Convulsion—Methotrexate—colon cancer	0.000213	0.00118	CcSEcCtD
Clomifene—Chest pain—Methotrexate—colon cancer	0.000209	0.00116	CcSEcCtD
Clomifene—Myalgia—Methotrexate—colon cancer	0.000209	0.00116	CcSEcCtD
Clomifene—Arthralgia—Methotrexate—colon cancer	0.000209	0.00116	CcSEcCtD
Clomifene—ABCB1—liver—colon cancer	0.000208	0.00664	CbGeAlD
Clomifene—Hypersensitivity—Capecitabine—colon cancer	0.000198	0.0011	CcSEcCtD
Clomifene—Asthenia—Capecitabine—colon cancer	0.000193	0.00107	CcSEcCtD
Clomifene—Pruritus—Capecitabine—colon cancer	0.00019	0.00106	CcSEcCtD
Clomifene—Diarrhoea—Capecitabine—colon cancer	0.000184	0.00102	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000182	0.00102	CcSEcCtD
Clomifene—Insomnia—Methotrexate—colon cancer	0.000181	0.00101	CcSEcCtD
Clomifene—Paraesthesia—Methotrexate—colon cancer	0.00018	0.001	CcSEcCtD
Clomifene—Dyspnoea—Methotrexate—colon cancer	0.000178	0.000994	CcSEcCtD
Clomifene—Dizziness—Capecitabine—colon cancer	0.000178	0.00099	CcSEcCtD
Clomifene—Fatigue—Methotrexate—colon cancer	0.000173	0.000961	CcSEcCtD
Clomifene—Pain—Methotrexate—colon cancer	0.000171	0.000953	CcSEcCtD
Clomifene—Vomiting—Capecitabine—colon cancer	0.000171	0.000952	CcSEcCtD
Clomifene—Rash—Capecitabine—colon cancer	0.00017	0.000944	CcSEcCtD
Clomifene—Dermatitis—Capecitabine—colon cancer	0.000169	0.000943	CcSEcCtD
Clomifene—Headache—Capecitabine—colon cancer	0.000168	0.000938	CcSEcCtD
Clomifene—Nausea—Capecitabine—colon cancer	0.00016	0.000889	CcSEcCtD
Clomifene—ABCB1—lymph node—colon cancer	0.00016	0.00509	CbGeAlD
Clomifene—Urticaria—Methotrexate—colon cancer	0.000159	0.000885	CcSEcCtD
Clomifene—Body temperature increased—Methotrexate—colon cancer	0.000158	0.000881	CcSEcCtD
Clomifene—Hypersensitivity—Methotrexate—colon cancer	0.000147	0.000821	CcSEcCtD
Clomifene—Asthenia—Methotrexate—colon cancer	0.000144	0.0008	CcSEcCtD
Clomifene—Pruritus—Methotrexate—colon cancer	0.000142	0.000789	CcSEcCtD
Clomifene—Diarrhoea—Methotrexate—colon cancer	0.000137	0.000763	CcSEcCtD
Clomifene—Dizziness—Methotrexate—colon cancer	0.000132	0.000737	CcSEcCtD
Clomifene—Vomiting—Methotrexate—colon cancer	0.000127	0.000709	CcSEcCtD
Clomifene—Rash—Methotrexate—colon cancer	0.000126	0.000703	CcSEcCtD
Clomifene—Dermatitis—Methotrexate—colon cancer	0.000126	0.000702	CcSEcCtD
Clomifene—Headache—Methotrexate—colon cancer	0.000125	0.000698	CcSEcCtD
Clomifene—Nausea—Methotrexate—colon cancer	0.000119	0.000662	CcSEcCtD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000104	0.00238	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—TGFB1—colon cancer	0.000104	0.00238	CbGpPWpGaD
Clomifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000104	0.00237	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000103	0.00235	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000103	0.00235	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000102	0.00235	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000102	0.00235	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—EGFR—colon cancer	0.000102	0.00233	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—MYC—colon cancer	0.000102	0.00233	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	0.000101	0.00233	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000101	0.00232	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	9.73e-05	0.00223	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—AKT1—colon cancer	9.55e-05	0.00219	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—EP300—colon cancer	9.53e-05	0.00219	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	9.42e-05	0.00216	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.4e-05	0.00216	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	9.38e-05	0.00215	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CA7—colon cancer	9.37e-05	0.00215	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	9.21e-05	0.00211	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	9.21e-05	0.00211	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	9.19e-05	0.00211	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	9.14e-05	0.0021	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	9.04e-05	0.00207	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—VEGFA—colon cancer	9.03e-05	0.00207	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ODC1—colon cancer	9.02e-05	0.00207	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CHST5—colon cancer	9.02e-05	0.00207	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—BRAF—colon cancer	8.91e-05	0.00204	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CA7—colon cancer	8.83e-05	0.00203	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	8.7e-05	0.002	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.5e-05	0.00195	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—colon cancer	8.35e-05	0.00191	CbGpPWpGaD
Clomifene—EBP—Metabolism—ABCB1—colon cancer	8.32e-05	0.00191	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	8.29e-05	0.0019	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	8.27e-05	0.0019	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	8.22e-05	0.00189	CbGpPWpGaD
Clomifene—EBP—Metabolism—TYMS—colon cancer	8.17e-05	0.00187	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	8.05e-05	0.00185	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CASP3—colon cancer	7.86e-05	0.0018	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	7.78e-05	0.00178	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	7.75e-05	0.00178	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—colon cancer	7.65e-05	0.00175	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	7.58e-05	0.00174	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—HRAS—colon cancer	7.55e-05	0.00173	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	7.4e-05	0.0017	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	7.24e-05	0.00166	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—AKT1—colon cancer	7.21e-05	0.00165	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—DLC1—colon cancer	7.18e-05	0.00165	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ODC1—colon cancer	7.18e-05	0.00165	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CHST5—colon cancer	7.18e-05	0.00165	CbGpPWpGaD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	7.15e-05	0.00164	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CA7—colon cancer	7.05e-05	0.00162	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	7.04e-05	0.00162	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	7.04e-05	0.00161	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	6.89e-05	0.00158	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	6.89e-05	0.00158	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	6.85e-05	0.00157	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	6.78e-05	0.00156	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—LGR5—colon cancer	6.75e-05	0.00155	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	6.7e-05	0.00154	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	6.7e-05	0.00154	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	6.67e-05	0.00153	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—AKT1—colon cancer	6.67e-05	0.00153	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	6.59e-05	0.00151	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	6.53e-05	0.0015	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	6.47e-05	0.00148	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	6.45e-05	0.00148	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	6.3e-05	0.00145	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.29e-05	0.00144	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	6.28e-05	0.00144	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	6.27e-05	0.00144	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—CASP3—colon cancer	6.25e-05	0.00143	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	6.14e-05	0.00141	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	6.13e-05	0.00141	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	6.01e-05	0.00138	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	6e-05	0.00138	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	5.99e-05	0.00137	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	5.97e-05	0.00137	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	5.96e-05	0.00137	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	5.87e-05	0.00135	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	5.87e-05	0.00135	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—NRAS—colon cancer	5.87e-05	0.00135	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.83e-05	0.00134	CbGpPWpGaD
Clomifene—EBP—Metabolism—PPARG—colon cancer	5.79e-05	0.00133	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	5.74e-05	0.00132	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.68e-05	0.0013	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ODC1—colon cancer	5.67e-05	0.0013	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CHST5—colon cancer	5.67e-05	0.0013	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	5.67e-05	0.0013	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CA7—colon cancer	5.63e-05	0.00129	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.62e-05	0.00129	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.62e-05	0.00129	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	5.55e-05	0.00127	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	5.55e-05	0.00127	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	5.49e-05	0.00126	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	5.49e-05	0.00126	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—EP300—colon cancer	5.38e-05	0.00123	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	5.37e-05	0.00123	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ODC1—colon cancer	5.35e-05	0.00123	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CHST5—colon cancer	5.35e-05	0.00123	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—EGFR—colon cancer	5.35e-05	0.00123	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—colon cancer	5.3e-05	0.00122	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	5.27e-05	0.00121	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	5.22e-05	0.0012	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.08e-05	0.00117	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	5.08e-05	0.00116	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—KRAS—colon cancer	5.05e-05	0.00116	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	5.04e-05	0.00116	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—TGFB1—colon cancer	5.01e-05	0.00115	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.95e-05	0.00113	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—TGFB1—colon cancer	4.87e-05	0.00112	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AXIN2—colon cancer	4.85e-05	0.00111	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	4.72e-05	0.00108	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	4.64e-05	0.00106	CbGpPWpGaD
Clomifene—EBP—Metabolism—PTGS2—colon cancer	4.55e-05	0.00104	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.55e-05	0.00104	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.54e-05	0.00104	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	4.51e-05	0.00103	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.45e-05	0.00102	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.42e-05	0.00101	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—HNF4A—colon cancer	4.4e-05	0.00101	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	4.38e-05	0.001	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CA7—colon cancer	4.35e-05	0.000997	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—HRAS—colon cancer	4.29e-05	0.000985	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CHST5—colon cancer	4.27e-05	0.00098	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ODC1—colon cancer	4.27e-05	0.00098	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.26e-05	0.000976	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.21e-05	0.000965	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—HRAS—colon cancer	4.1e-05	0.00094	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—PPARG—colon cancer	3.97e-05	0.00091	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	3.91e-05	0.000896	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.86e-05	0.000886	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	3.81e-05	0.000874	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—AKT1—colon cancer	3.79e-05	0.000869	CbGpPWpGaD
Clomifene—EBP—Metabolism—EP300—colon cancer	3.79e-05	0.000869	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.74e-05	0.000858	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.72e-05	0.000854	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.68e-05	0.000844	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.63e-05	0.000832	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ABCB1—colon cancer	3.6e-05	0.000826	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—TYMS—colon cancer	3.53e-05	0.000811	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ODC1—colon cancer	3.41e-05	0.000783	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CHST5—colon cancer	3.41e-05	0.000783	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	3.32e-05	0.000762	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.16e-05	0.000724	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	3.08e-05	0.000708	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	3e-05	0.000689	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.97e-05	0.000682	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.93e-05	0.000672	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.9e-05	0.000666	CbGpPWpGaD
Clomifene—EBP—Metabolism—PIK3CA—colon cancer	2.8e-05	0.000643	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	2.76e-05	0.000634	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.72e-05	0.000624	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	2.69e-05	0.000617	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CHST5—colon cancer	2.63e-05	0.000604	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ODC1—colon cancer	2.63e-05	0.000604	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	2.62e-05	0.0006	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PPARG—colon cancer	2.5e-05	0.000574	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.44e-05	0.000559	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	2.41e-05	0.000552	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	2.4e-05	0.000551	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ABCB1—colon cancer	2.38e-05	0.000547	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	2.36e-05	0.00054	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—TYMS—colon cancer	2.34e-05	0.000537	CbGpPWpGaD
Clomifene—EBP—Metabolism—AKT1—colon cancer	2.29e-05	0.000525	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—colon cancer	2.26e-05	0.000519	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	2.23e-05	0.00051	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.21e-05	0.000507	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	2.04e-05	0.000469	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.98e-05	0.000454	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—colon cancer	1.97e-05	0.000452	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—PPARG—colon cancer	1.91e-05	0.000438	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ABCB1—colon cancer	1.9e-05	0.000435	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—TYMS—colon cancer	1.86e-05	0.000427	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.8e-05	0.000413	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.74e-05	0.000399	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.67e-05	0.000383	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PPARG—colon cancer	1.66e-05	0.00038	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—EP300—colon cancer	1.64e-05	0.000376	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ABCB1—colon cancer	1.5e-05	0.000344	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TYMS—colon cancer	1.47e-05	0.000338	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.45e-05	0.000331	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ABCB1—colon cancer	1.41e-05	0.000324	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.41e-05	0.000323	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FGFR3—colon cancer	1.4e-05	0.000321	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TYMS—colon cancer	1.39e-05	0.000319	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PPARG—colon cancer	1.32e-05	0.000303	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—colon cancer	1.3e-05	0.000299	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—APC—colon cancer	1.29e-05	0.000295	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PIK3CA—colon cancer	1.21e-05	0.000278	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—BRAF—colon cancer	1.21e-05	0.000277	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TYMS—colon cancer	1.11e-05	0.000254	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.11e-05	0.000254	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—colon cancer	1.09e-05	0.00025	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—EP300—colon cancer	1.09e-05	0.000249	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.07e-05	0.000245	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PPARG—colon cancer	1.04e-05	0.000239	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—colon cancer	1.04e-05	0.000238	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AKT1—colon cancer	9.9e-06	0.000227	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PPARG—colon cancer	9.84e-06	0.000226	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.21e-06	0.000211	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CASP3—colon cancer	9.07e-06	0.000208	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ABCB1—colon cancer	9.01e-06	0.000207	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TYMS—colon cancer	8.85e-06	0.000203	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—colon cancer	8.83e-06	0.000202	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—colon cancer	8.74e-06	0.0002	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—EP300—colon cancer	8.64e-06	0.000198	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CDKN1A—colon cancer	8.54e-06	0.000196	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—colon cancer	8.21e-06	0.000188	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EP300—colon cancer	8.12e-06	0.000186	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PIK3CA—colon cancer	8.03e-06	0.000184	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SRC—colon cancer	7.9e-06	0.000181	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PPARG—colon cancer	7.86e-06	0.00018	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—colon cancer	7.74e-06	0.000177	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—colon cancer	7.69e-06	0.000176	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—colon cancer	7.6e-06	0.000174	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—AKT1—colon cancer	7.55e-06	0.000173	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—colon cancer	7.08e-06	0.000162	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TGFB1—colon cancer	7.06e-06	0.000162	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ABCB1—colon cancer	6.96e-06	0.00016	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—colon cancer	6.92e-06	0.000159	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TYMS—colon cancer	6.83e-06	0.000157	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—EP300—colon cancer	6.83e-06	0.000157	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.82e-06	0.000156	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AKT1—colon cancer	6.56e-06	0.00015	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—colon cancer	6.54e-06	0.00015	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—EP300—colon cancer	6.44e-06	0.000148	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PIK3CA—colon cancer	6.39e-06	0.000147	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PPARG—colon cancer	6.27e-06	0.000144	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—colon cancer	6.18e-06	0.000142	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PIK3CA—colon cancer	6.01e-06	0.000138	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—colon cancer	5.81e-06	0.000133	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—colon cancer	5.56e-06	0.000128	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AKT1—colon cancer	5.22e-06	0.00012	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—EP300—colon cancer	5.14e-06	0.000118	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PIK3CA—colon cancer	5.05e-06	0.000116	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—colon cancer	4.93e-06	0.000113	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AKT1—colon cancer	4.91e-06	0.000113	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PPARG—colon cancer	4.84e-06	0.000111	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PIK3CA—colon cancer	4.76e-06	0.000109	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AKT1—colon cancer	4.12e-06	9.46e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—EP300—colon cancer	4.1e-06	9.41e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AKT1—colon cancer	3.89e-06	8.92e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—colon cancer	3.81e-06	8.73e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PIK3CA—colon cancer	3.8e-06	8.72e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—EP300—colon cancer	3.17e-06	7.26e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AKT1—colon cancer	3.11e-06	7.12e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PIK3CA—colon cancer	3.04e-06	6.96e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AKT1—colon cancer	2.48e-06	5.69e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PIK3CA—colon cancer	2.34e-06	5.37e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AKT1—colon cancer	1.91e-06	4.39e-05	CbGpPWpGaD
